A computer model developed by Cleveland Clinic oncologist Timothy Chan, MD, PhD, and colleagues accurately predicts whether immune checkpoint blockade will be effective in patients diagnosed with a wide variety of cancers.
Advancing Immunotherapy: A Conversation with Timothy Chan, MD, PhD
Timothy Chan, MD, PhD, the renowned cancer researcher who directs Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology, plans to use genomic analysis and high-throughput immunoprofiling to develop advanced targeted therapies.